Announcing the 3rd Canadian consensus manuscript: First Line Treatment of Newly Diagnosed Transplant Ineligible Multiple Myeloma
To address the needs of physicians and people diagnosed with multiple myeloma, Myeloma Canada has been le...
Read moreResearch & Access Updates
Myeloma research at the 64th American Society of Hematology (ASH) Annual Meeting and Exposition
Myeloma Canada, along with thousands from the global hematology community, had the privilege of attending...
Read moreNova Scotia Department of Health and Wellness is seeking for your feedback
The Nova Scotia Department of Health and Wellness is seeking feedback from the public on discrimination i...
Read moreGovernment of Canada improves sickness benefits under the Employment Insurance system
Canadians who are facing illness or injury need to feel confident that they are supported and that their...
Read moreNEW AND EXCLUSIVE: Myeloma Canada Is Participating in the Pilot Project of Clinical Trials Quebec’s Personalized Support Service
Myeloma Canada is proud to announce that it has joined Clinical Trials Quebec’s Personalized Support Serv...
Read moreLower Risk of Smoldering Multiple Myeloma Progression Among African Americans
Smoldering multiple myeloma (SMM) is less likely to progress to active multiple myeloma (MM) among Africa...
Read more